The results showed that CSF NfL had a higher diagnostic value in MS patients, with an area under the ROC curve (AUC) of 0.836 (0.544–0.824; p < 0.001), sensitivity of 0.78, and specificity and 0.77, compared to CSF RTN4 and tau. Here, MAPT is linked to myeloid sarcoma.